Company: FVN
Filing Date: 2025-05-02
Form Type: S-4
Source: 0001829126-25-003304
Chunk: 157

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-02
Form: S-4
Chunk 157
---
 public market for New VIWO’s ordinary shares does not develop, investors may not be able to re-sell their ordinary shares, rendering their shares illiquid and possibly resulting in a complete loss of their investment. New VIWO cannot predict the extent to which investor interest in us will lead to the development of an active, liquid trading market. The trading price of and demand for the ordinary shares of us and the development and continued existence of a market and favorable price for the ordinary shares of us will depend on a number of conditions, including the development of a market following, including by analysts and other investment professionals, the businesses, operations, results and prospects of us, general market and economic conditions, governmental actions, regulatory considerations, legal proceedings and developments or other factors. These and other factors may impair the development of a liquid market and the ability of investors to sell shares at an attractive price. These factors also could cause the market price and demand for the ordinary shares of us to fluctuate substantially, which may limit or prevent investors from readily selling their shares and may otherwise affect negatively the price and liquidity of the ordinary shares of us. Many of these factors and conditions are beyond the control of us or New VIWO’s shareholders.

New VIWO may be unable to obtain additional financing to fund its operations or growth.

New VIWO may require additional financing to fund its operations or growth. The failure to secure additional financing could have a material adverse effect on the continued development or growth of New VIWO. None of New VIWO’s officers, directors or shareholders is required to provide any financing to New VIWO in connection with or after the business combination.

<div align='center'>87</div>

New VIWO may be subject to securities litigation, which is expensive and could divert management attention.

The market price of New VIWO’s ordinary shares may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. New VIWO may be the target of this type of litigation in the future. Securities litigation against New VIWO could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm New VIWO’s business.

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about New VIWO or its business, its ordinary shares price and trading volume could decline.

The trading market for New VIWO’s ordinary shares will depend in part on the research and reports that securities or industry analysts publish about New VIWO or its business. Securities and